Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases

NCT07780890 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07780890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07780890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
August 18, 2026
Completion date
September 1, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded), fuchs endothelial corneal dysfunction, keratoconus, lasik eye surgery, open angle glaucoma (oag)